AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35871319 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study 33404997 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable cardioverter defibrillators (WCD)
Number of subjects: 0
Study 33404997 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous implantable cardioverter defibrillators (S-ICDs)
Number of subjects: 0
Study 33460198 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin Enacarbil Extended-Release (GE-XR) 600 mg twice-a-day
Number of subjects: 338
Study 33460198 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 338
Study 33586615 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat stress (HS)
Number of subjects: 2
Study 33586615 — intervention group
Group type: COMPARATOR
Intervention: Non-heat-stressed condition (NC)
Number of subjects: 2
Study 33586615 — intervention group
Group type: EXPERIMENTAL
Intervention: RNA sequencing and qRT-PCR
Number of subjects: 2
Study 33586615 — intervention group
Group type: EXPERIMENTAL
Intervention: GO annotation and KEGG analysis
Number of subjects: 2
Study 34562391 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 50 mg/kg per day for 7 days
Number of subjects: 432
Study 34562391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 432
Study 32682735 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative video about mandibular third molar removal
Number of subjects: 47
Study 32682735 — intervention group
Group type: COMPARATOR
Intervention: No informative video (control group)
Number of subjects: 47
Study 33413034 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group (TG) - 15 weeks of combined aerobic exercise and strength training, 90-min supervised sessions weekly, encouraged home-based training 30 min/week
Number of subjects: 45
Study 33413034 — intervention group
Group type: COMPARATOR
Intervention: Inactive control group (CG)
Number of subjects: 45
Study 33866269 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT) imaging
Number of subjects: 174
Study 33866269 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound (US) imaging
Number of subjects: 174
Study 35263425 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 36
Study 35263425 — intervention group
Group type: COMPARATOR
Intervention: Dapagliflozin
Number of subjects: 36
Study 35263425 — intervention group
Group type: COMPARATOR
Intervention: Acarbose
Number of subjects: 36
Study 33158945 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard limb RYGB (50‐cm biliopancreatic limb)
Number of subjects: 53
Study 33158945 — intervention group
Group type: COMPARATOR
Intervention: Long limb RYGB (150‐cm biliopancreatic limb)
Number of subjects: 53
Study 32579859 — intervention group
Group type: EXPERIMENTAL
Intervention: Telepractice voice therapy
Number of subjects: 69
Study 32579859 — intervention group
Group type: COMPARATOR
Intervention: Conventional voice therapy
Number of subjects: 69
Study 35584484 — intervention group
Group type: EXPERIMENTAL
Intervention: Seating system + exercise (SSE-group; n=15)
Number of subjects: 29
Study 35584484 — intervention group
Group type: COMPARATOR
Intervention: Exercise (E-group; n=14)
Number of subjects: 29
Study 34271952 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care supplemented by five group-based cognitive therapy sessions performed by trained CR nurses
Number of subjects: 148
Study 34271952 — intervention group
Group type: COMPARATOR
Intervention: Usual out-patient cardiac rehabilitation (CR) comprising an 8-week multidisciplinary programme
Number of subjects: 148
Study 34086521 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-befriending intervention
Number of subjects: 28
Study 32991508 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercises (12-week program)
Number of subjects: 109
Study 32991508 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 54)
Number of subjects: 109
Study 34243938 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 90
Study 34243938 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 90
Study 35779016 — intervention group
Group type: EXPERIMENTAL
Intervention: Fracture Liaison Service (FLS) pathway for osteoporosis management
Number of subjects: 491
Study 32162045 — intervention group
Group type: EXPERIMENTAL
Intervention: Repair with additional internal bracing using two anchors (group II)
Number of subjects: 21
Study 32162045 — intervention group
Group type: EXPERIMENTAL
Intervention: Repair using one humeral anchor (group III)
Number of subjects: 21
Study 32162045 — intervention group
Group type: COMPARATOR
Intervention: Repair alone (group I)
Number of subjects: 21
Study 35550508 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year low-dose metronomic methotrexate-based chemotherapy
Number of subjects: 0
Study 35550508 — intervention group
Group type: COMPARATOR
Intervention: No maintenance chemotherapy
Number of subjects: 0
Study 34895435 — intervention group
Group type: EXPERIMENTAL
Intervention: Christmas hats
Number of subjects: 33
Study 34895435 — intervention group
Group type: EXPERIMENTAL
Intervention: Reindeer antlers
Number of subjects: 33
Study 34895435 — intervention group
Group type: EXPERIMENTAL
Intervention: Small black bars
Number of subjects: 33
Study 34895435 — intervention group
Group type: EXPERIMENTAL
Intervention: Large black bars
Number of subjects: 33
Study 34895435 — intervention group
Group type: EXPERIMENTAL
Intervention: T-shapes
Number of subjects: 33
Study 34895435 — intervention group
Group type: COMPARATOR
Intervention: Unmodified photos
Number of subjects: 33
Study 35749510 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives for ART adherence
Number of subjects: 49
Study 33952397 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glucose control
Number of subjects: 9405
Study 33952397 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 9405
Study 32487180 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Club Denmark intervention group
Number of subjects: 0
Study 32487180 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 35043012 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction drainage
Number of subjects: 40
Study 35043012 — intervention group
Group type: COMPARATOR
Intervention: No suction drainage (control)
Number of subjects: 40
Study 33953794 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP positive expression before radiotherapy
Number of subjects: 95
Study 33953794 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP levels post-radiotherapy
Number of subjects: 95
Study 33953794 — intervention group
Group type: EXPERIMENTAL
Intervention: SCC and CEA levels
Number of subjects: 95
Study 33953794 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest CT examination for short-term efficacy evaluation
Number of subjects: 95
Study 33121536 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel intervention including provider and staff education, provider reminder, provider assessment and feedback, patient reminder, and patient navigation.
Number of subjects: 4
Study 33121536 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention components implemented during the 3-month waiting period).
Number of subjects: 4
Study 35931957 — intervention group
Group type: EXPERIMENTAL
Intervention: Single plasma exchange
Number of subjects: 5
Study 35931957 — intervention group
Group type: COMPARATOR
Intervention: Double filtration plasmapheresis (DFPP)
Number of subjects: 5
Study 34793890 — intervention group
Group type: EXPERIMENTAL
Intervention: WebQuest educational strategy
Number of subjects: 100
Study 34793890 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 100
Study 34519620 — intervention group
Group type: EXPERIMENTAL
Intervention: fSKEPT with conflict-related treatment focus
Number of subjects: 81
Study 34519620 — intervention group
Group type: EXPERIMENTAL
Intervention: fSKEPT with personality functioning-specific interventions
Number of subjects: 81
Study 34519620 — intervention group
Group type: EXPERIMENTAL
Intervention: fSKEPT with unspecific interventions
Number of subjects: 81
Study 34519620 — intervention group
Group type: EXPERIMENTAL
Intervention: fSKEPT with conflict focus
Number of subjects: 81
Study 32859477 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 3451
Study 32859477 — intervention group
Group type: COMPARATOR
Intervention: No Hydroxychloroquine (Control)
Number of subjects: 3451
Study 35897358 — intervention group
Group type: EXPERIMENTAL
Intervention: LLLT (Low-Level Laser Therapy)
Number of subjects: 32
Study 35897358 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Conservative Treatment
Number of subjects: 32
Study 35897358 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of LLLT and Standard Conservative Treatment
Number of subjects: 32
Study 35897358 — intervention group
Group type: COMPARATOR
Intervention: LLLT
Number of subjects: 32
Study 33497850 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training (CWMT)
Number of subjects: 30
Study 33497850 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 30
Study 33143361 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 0
Study 33143361 — intervention group
Group type: COMPARATOR
Intervention: Chromotherapy room
Number of subjects: 0
Study 35119537 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Navigation (PN) intervention
Number of subjects: 113
Study 35119537 — intervention group
Group type: COMPARATOR
Intervention: Control (trans-friendly HIV care)
Number of subjects: 113
Study 33947376 — intervention group
Group type: EXPERIMENTAL
Intervention: BIO Mesh Closure
Number of subjects: 0
Study 33947376 — intervention group
Group type: COMPARATOR
Intervention: Glued Closure
Number of subjects: 0
Study 34734361 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploring Together (ET)
Number of subjects: 136
Study 34734361 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploring Together-Adapted (ET-Adapted)
Number of subjects: 136
Study 33998290 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 0
Study 33998290 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 0
Study 32090764 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate adherence to Traditional Mediterranean Dietary Pattern (MDP)
Number of subjects: 545
Study 32090764 — intervention group
Group type: EXPERIMENTAL
Intervention: High adherence to Traditional Mediterranean Dietary Pattern (MDP)
Number of subjects: 545
Study 32090764 — intervention group
Group type: COMPARATOR
Intervention: Brazilian Mediterranean Dietary Pattern (MDP)
Number of subjects: 545
Study 36421357 — intervention group
Group type: EXPERIMENTAL
Intervention: DCG emotional support
Number of subjects: 314
Study 36421357 — intervention group
Group type: EXPERIMENTAL
Intervention: DCG self-efficacy
Number of subjects: 314
Study 36421357 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient anxiety
Number of subjects: 314
Study 36421357 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient depression
Number of subjects: 314
Study 36421357 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall burden in DCGs
Number of subjects: 314
Study 33556350 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN) combined with eccentric exercise (EE)
Number of subjects: 48
Study 33556350 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous needle electrolysis (PNE) combined with eccentric exercise (EE)
Number of subjects: 48
Study 33556350 — intervention group
Group type: COMPARATOR
Intervention: Eccentric exercise (EE) with sham needle (control group)
Number of subjects: 48
Study 33198147 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief relaxation practice
Number of subjects: 31
Study 33198147 — intervention group
Group type: COMPARATOR
Intervention: Viewing greenery images
Number of subjects: 31
Study 33198147 — intervention group
Group type: COMPARATOR
Intervention: Control task
Number of subjects: 31
Study 35653355 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable supportive shoes
Number of subjects: 28
Study 35653355 — intervention group
Group type: COMPARATOR
Intervention: Flat flexible shoes
Number of subjects: 28
Study 35298285 — intervention group
Group type: EXPERIMENTAL
Intervention: Fayton Q‐switched 1064 nm Nd:YAG laser with a spot diameter of 9 mm and an energy density of 0.8 J/cm2
Number of subjects: 30
Study 35298285 — intervention group
Group type: EXPERIMENTAL
Intervention: Fayton Q‐switched 1064 nm Nd:YAG laser with a spot diameter of 6 mm and an energy density of 1.2 J/cm2
Number of subjects: 30
Study 32578032 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 0
Study 32578032 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of IVF and ICSI on sibling oocytes
Number of subjects: 0
Study 32578032 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 0
Study 33662301 — intervention group
Group type: EXPERIMENTAL
Intervention: FLACSg (600 μm grid)
Number of subjects: 93
Study 33662301 — intervention group
Group type: COMPARATOR
Intervention: PE (phacoemulsification)
Number of subjects: 93
Study 33662301 — intervention group
Group type: EXPERIMENTAL
Intervention: FLACS16 (16-segment fragmentation)
Number of subjects: 93
Study 32406383 — intervention group
Group type: EXPERIMENTAL
Intervention: Video game intervention during intravenous cannulation
Number of subjects: 0
Study 32406383 — intervention group
Group type: COMPARATOR
Intervention: Control group (no video game intervention)
Number of subjects: 0
Study 34292258 — intervention group
Group type: EXPERIMENTAL
Intervention: StandingTall, a home-based fall prevention program delivered through a tablet computer
Number of subjects: 50
Study 33340731 — intervention group
Group type: EXPERIMENTAL
Intervention: 1470-nm laser with bare fiber (BF)
Number of subjects: 86
Study 33340731 — intervention group
Group type: EXPERIMENTAL
Intervention: 1470-nm laser with radial fiber (RF)
Number of subjects: 86
Study 32554833 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga group
Number of subjects: 14
Study 32554833 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study 36476809 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided out-of-plane cannulation of the internal jugular vein (IJV)
Number of subjects: 610
Study 36476809 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided in-plane infraclavicular cannulation of the axillary vein (AXV)
Number of subjects: 610
Study 32926247 — intervention group
Group type: EXPERIMENTAL
Intervention: IV golimumab 2 mg/kg at weeks 0, 4, then every 8 weeks through week 52
Number of subjects: 208
Study 32926247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study 32926247 — intervention group
Group type: EXPERIMENTAL
Intervention: IV golimumab 2 mg/kg
Number of subjects: 208
Study 32926247 — intervention group
Group type: COMPARATOR
Intervention: Placebo-crossover to IV golimumab
Number of subjects: 208
Study 32810697 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft-soled sneakers
Number of subjects: 47
Study 32810697 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft-soled boots
Number of subjects: 47
Study 32810697 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft-soled sandals
Number of subjects: 47
Study 32810697 — intervention group
Group type: COMPARATOR
Intervention: Barefoot
Number of subjects: 47
Study 35122457 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity prevention interventions
Number of subjects: 161
Study 34129204 — intervention group
Group type: EXPERIMENTAL
Intervention: BiPAP
Number of subjects: 284
Study 34129204 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 284
Study 33289845 — intervention group
Group type: EXPERIMENTAL
Intervention: DCE-MRI radiomic signature
Number of subjects: 1214
Study 33289845 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical-radiomic nomogram
Number of subjects: 1214
Study 34637495 — intervention group
Group type: EXPERIMENTAL
Intervention: mySmartCheck (automated internet-based intervention)
Number of subjects: 116
Study 34637495 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 116
Study 34878013 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational workshops about bonding with the fetus
Number of subjects: 19
Study 34878013 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 19
Study 33989966 — intervention group
Group type: EXPERIMENTAL
Intervention: Texture analysis (TA)
Number of subjects: 90
Study 33989966 — intervention group
Group type: COMPARATOR
Intervention: Qualitative ratings by radiologists
Number of subjects: 90
Study 36201208 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance at a high-performing public charter high school
Number of subjects: 1270
Study 33965414 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretarsal (PTS) BoNT‐A injection
Number of subjects: 24
Study 33965414 — intervention group
Group type: COMPARATOR
Intervention: Preseptal (PST) BoNT‐A injection
Number of subjects: 24
Study 33965414 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PTS and PST BoNT‐A injections
Number of subjects: 24
Study 32108437 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting liver metastasis in pancreatic cancer
Number of subjects: 604
Study 35605520 — intervention group
Group type: EXPERIMENTAL
Intervention: Eustachian tube insufflation with thermal water
Number of subjects: 74
Study 33238798 — intervention group
Group type: EXPERIMENTAL
Intervention: Myo-inositol (2g) plus folic acid (200µg)
Number of subjects: 223
Study 33238798 — intervention group
Group type: COMPARATOR
Intervention: Placebo (200µg of folic acid)
Number of subjects: 223
Study 33147205 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous reduction and hollow screw fixation (PRHCF)
Number of subjects: 71
Study 33147205 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 71
Study 33147205 — intervention group
Group type: EXPERIMENTAL
Intervention: PRHCF
Number of subjects: 71
Study 34541914 — intervention group
Group type: EXPERIMENTAL
Intervention: DL‐beta‐hydroxybutyrate
Number of subjects: 41
Study 34541914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 32778159 — intervention group
Group type: EXPERIMENTAL
Intervention: Blog-delivered healthy eating intervention
Number of subjects: 84
Study 32778159 — intervention group
Group type: COMPARATOR
Intervention: Facebook recruitment method
Number of subjects: 84
Study 32778159 — intervention group
Group type: COMPARATOR
Intervention: Traditional recruitment methods
Number of subjects: 84
Study 34543256 — intervention group
Group type: EXPERIMENTAL
Intervention: NGAL/hepcidin-25 ratio
Number of subjects: 198
Study 34949566 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrieval Practice (RP) with anodal tDCS
Number of subjects: 119
Study 34949566 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrieval Practice (RP) with sham stimulation
Number of subjects: 119
Study 34949566 — intervention group
Group type: COMPARATOR
Intervention: Restudy with anodal tDCS
Number of subjects: 119
Study 34949566 — intervention group
Group type: COMPARATOR
Intervention: Restudy with sham stimulation
Number of subjects: 119
Study 34949566 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrieval Practice (RP)
Number of subjects: 119
Study 34949566 — intervention group
Group type: COMPARATOR
Intervention: Restudy
Number of subjects: 119
Study 34506563 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel formula for predicting cirrhosis based on ln type IV collagen 7S, ln hyaluronic acid, and ln WFA+‐Mac‐2 BP.
Number of subjects: 749
Study 34506563 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel formula scores
Number of subjects: 749
Study 34506563 — intervention group
Group type: COMPARATOR
Intervention: Conventional fibrosis markers and indices
Number of subjects: 749
Study 34082279 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session computerized anxiety sensitivity intervention
Number of subjects: 68
Study 34082279 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 68
Study 34237041 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Anterior Approach (DAA)
Number of subjects: 75
Study 34237041 — intervention group
Group type: COMPARATOR
Intervention: Posterior Approach (PA)
Number of subjects: 75
Study 32824387 — intervention group
Group type: EXPERIMENTAL
Intervention: K-diet
Number of subjects: 10
Study 32824387 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 10
Study 33247555 — intervention group
Group type: EXPERIMENTAL
Intervention: Cool Little Kids program
Number of subjects: 545
Study 33247555 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 545
Study 33380579 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal dexmedetomidine (5 μg) with 8 mg bupivacaine
Number of subjects: 80
Study 33380579 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal sufentanil (2.5 μg) with 8 mg bupivacaine
Number of subjects: 80
Study 34237810 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental biopsy group (MRI with targeted and standard biopsy)
Number of subjects: 1532
Study 34237810 — intervention group
Group type: COMPARATOR
Intervention: Standard biopsy group
Number of subjects: 1532
Study 32298418 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact force-guided catheter ablation (CA)
Number of subjects: 156
Study 32298418 — intervention group
Group type: COMPARATOR
Intervention: Blinded to contact force (control group)
Number of subjects: 156
Study 35389015 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser with 1% terbinafine cream
Number of subjects: 100
Study 35389015 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole (one-week pulse therapy)
Number of subjects: 100
Study 34245857 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) > 3.33 mg/l
Number of subjects: 0
Study 34245857 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity CRP assay
Number of subjects: 0
Study 34245857 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperational CRP
Number of subjects: 0
Study 34245857 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP-to-albumin ratio and Glasgow Prognostic Score (GPS)
Number of subjects: 0
Study 33484158 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined massage and warm compress to the perineum (MassComp)
Number of subjects: 156